DK272383A - Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet - Google Patents

Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet Download PDF

Info

Publication number
DK272383A
DK272383A DK272383A DK272383A DK272383A DK 272383 A DK272383 A DK 272383A DK 272383 A DK272383 A DK 272383A DK 272383 A DK272383 A DK 272383A DK 272383 A DK272383 A DK 272383A
Authority
DK
Denmark
Prior art keywords
active substance
annual
taste
stability
increase
Prior art date
Application number
DK272383A
Other languages
English (en)
Other versions
DK161365C (da
DK161365B (da
DK272383D0 (da
Inventor
Anders Goeran Vilh Kaellstrand
Kjell Johan Mattsson
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of DK272383D0 publication Critical patent/DK272383D0/da
Publication of DK272383A publication Critical patent/DK272383A/da
Publication of DK161365B publication Critical patent/DK161365B/da
Application granted granted Critical
Publication of DK161365C publication Critical patent/DK161365C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK272383A 1982-06-24 1983-06-14 Flydende farmaceutisk praeparat til oral indgivelse med kontrolleret frigivelse og god stabilitet, samt fremgangsmaade til fremstilling heraf DK161365C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture
SE8203953 1982-06-24

Publications (4)

Publication Number Publication Date
DK272383D0 DK272383D0 (da) 1983-06-14
DK272383A true DK272383A (da) 1983-12-25
DK161365B DK161365B (da) 1991-07-01
DK161365C DK161365C (da) 1991-12-09

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272383A DK161365C (da) 1982-06-24 1983-06-14 Flydende farmaceutisk praeparat til oral indgivelse med kontrolleret frigivelse og god stabilitet, samt fremgangsmaade til fremstilling heraf

Country Status (29)

Country Link
EP (1) EP0101418B1 (da)
JP (1) JPS5916822A (da)
KR (1) KR910000028B1 (da)
AR (1) AR231075A1 (da)
AT (1) ATE59286T1 (da)
AU (1) AU561954B2 (da)
BG (1) BG51341A3 (da)
CA (1) CA1214726A (da)
CS (1) CS257769B2 (da)
CY (1) CY1468A (da)
DD (1) DD209971A5 (da)
DE (1) DE3382086D1 (da)
DK (1) DK161365C (da)
ES (1) ES523536A0 (da)
FI (1) FI85213C (da)
GB (1) GB2122490B (da)
GR (1) GR78604B (da)
HK (1) HK98786A (da)
HU (1) HU189300B (da)
IE (1) IE55204B1 (da)
IS (1) IS1325B6 (da)
MY (1) MY8700292A (da)
NO (1) NO168745C (da)
NZ (1) NZ204639A (da)
PH (1) PH21911A (da)
PT (1) PT76919B (da)
SE (1) SE8203953D0 (da)
SU (1) SU1722207A3 (da)
ZA (1) ZA833931B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
JPH03504968A (ja) * 1988-04-19 1991-10-31 サウスウェスト・リサーチ・インスティチュート 塩感受性シェル物質を有するカプセルからの活性成分の制御放出
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
JP3470198B2 (ja) * 1995-05-02 2003-11-25 大正製薬株式会社 経口投与用組成物
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (da) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
ES434971A1 (es) * 1974-02-22 1977-05-16 Wellcome Found Metodo para producir un preparado farmaceutico que comprendeuna solucin de digoxina en una envolvente de capsula solu- ble.
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
ATE59286T1 (de) 1991-01-15
FI832197A0 (fi) 1983-06-16
CY1468A (en) 1989-07-21
ZA833931B (en) 1984-07-25
GR78604B (da) 1984-09-27
FI85213B (fi) 1991-12-13
AR231075A1 (es) 1984-09-28
DK161365C (da) 1991-12-09
JPS5916822A (ja) 1984-01-28
GB2122490A (en) 1984-01-18
ES8403720A1 (es) 1984-04-01
JPH0559089B2 (da) 1993-08-30
BG51341A3 (en) 1993-04-15
CA1214726A (en) 1986-12-02
SE8203953D0 (sv) 1982-06-24
HU189300B (en) 1986-06-30
EP0101418A3 (en) 1984-11-14
AU561954B2 (en) 1987-05-21
AU1594383A (en) 1984-01-05
HK98786A (en) 1986-12-24
EP0101418B1 (en) 1990-12-27
NZ204639A (en) 1986-01-24
NO832293L (no) 1983-12-27
NO168745B (no) 1991-12-23
IE55204B1 (en) 1990-07-04
MY8700292A (en) 1987-12-31
PT76919B (en) 1986-04-09
DE3382086D1 (de) 1991-02-07
IE831462L (en) 1983-12-24
FI832197L (fi) 1983-12-25
PH21911A (en) 1988-04-08
SU1722207A3 (ru) 1992-03-23
IS2824A7 (is) 1983-12-25
PT76919A (en) 1983-07-01
NO168745C (no) 1992-04-01
IS1325B6 (is) 1988-08-03
GB2122490B (en) 1986-04-03
FI85213C (fi) 1992-03-25
ES523536A0 (es) 1984-04-01
KR840005024A (ko) 1984-11-03
EP0101418A2 (en) 1984-02-22
DD209971A5 (de) 1984-05-30
KR910000028B1 (ko) 1991-01-19
GB8317071D0 (en) 1983-07-27
DK161365B (da) 1991-07-01
CS463683A2 (en) 1987-11-12
CS257769B2 (en) 1988-06-15
DK272383D0 (da) 1983-06-14

Similar Documents

Publication Publication Date Title
DK272383A (da) Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet
DK158032C (da) Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
DK157031C (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf til anvendelse som udgangsmaterialer i fremgangsmaaden
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK19877A (da) Substituerede n-phenyl-n'-benzoylurinstoffer fremgangsmade til deres fremstilling og deres anvendelse som insecticider
NO831873L (no) Fremgangsmaate for fremstilling av nye alkan- og alkenderivater
DK164203C (da) Praeparat til indgift af systemisk virkende forbindelser via slimhinder
DK371277A (da) Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning
DK189581A (da) Hidtil ukendte heparinestere der er anvendelige til fremstilling af laegemidler og fremgangsmaader til deres frmstilling
DK77580A (da) Fremgangsmaade til fremstilling af beta-lactamholdige forbindelser isaer penemcarboxylsyrer
DK379380A (da) Fremgangsmaade til fremstilling af 1-aminocyclopropan-carbolsyre og derivater deraf
DK537685D0 (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK209383D0 (da) Fremgangsmade til fremstilling af aziridin- og phenylethanolaminderivater
DK445078A (da) Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf
DK11480A (da) Fremgangsmaade til fremstilling af anthracyclinderivater og syreadditionssalte deraf
DK20580A (da) Kosmetiske midler og fremgangsmaade til fremstilling af deres aktive ingredienser
DK536281A (da) Fremgangsmaade til fremstilling af carbonsyrederivater
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
SE7604317L (sv) Fast farmaceutisk doseringsform med fordrojd frigoring och sett att framstella desamma
NO830238L (no) Fremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer
DK53483D0 (da) Fremgangsmade til fremstilling af guanidinderivater
NO790765L (no) Fremgangsmaate til fremstilling av urinstoffer og amidoforbindelser

Legal Events

Date Code Title Description
PUP Patent expired